Scientists at Edinburgh are to help develop cutting edge technologies at a new £100m research centre.
The Rosalind Franklin Institute will bring together scientists from across the UK who will seek to transform our understanding of disease and speed up the development of new treatments.
The centre was announced by Business Secretary Greg Clark.
The Government-backed venture will see researchers across the University work with colleagues at six partner institutions.
Named after one of the UK’s leading chemists, the new Rosalind Franklin Institute will inspire and house scientists who could be responsible for the next great discovery that will maintain the UK’s position at the forefront of global science for years to come.
Rosalind Franklin, the pioneering British scientist, used X-rays to study biological structures and played a crucial role in the discovery of DNA’s double helix structure by Francis Crick and James Watson.
The centre will bring together expertise in engineering and the physical and life sciences. They will aim to develop technologies to tackle major challenges in health and life sciences.
It will also accelerate the discovery of new treatments for chronic diseases affecting millions of people around the world.
The centre seeks to deliver new jobs and long-term growth to the local and UK economies.
The central hub at Harwell, Oxfordshire, will link to partner sites at the Universities of Cambridge, Edinburgh, Manchester and Oxford, Imperial College, King’s College London, and University College London.
Industry partners will be on board from the outset.
The institute will be funded and managed by the Engineering and Physical Sciences Research Council.
It is fantastic that Edinburgh, with its demonstrated combination of research excellence across the physical and life sciences, engineering and medicine, will be a founding partner in the Rosalind Franklin Institute. This flagship institute will enable partnership between the physical and life sciences, driving the development of breakthrough tools and technologies and their application to discovery and innovation across biology, medicine and healthcare. We look forward to Edinburgh playing a key role in these developments.